Biological Material Transfer Agreement Template for the United Arab Emirates

When you're involved in biological research or biotechnology in the United Arab Emirates, you need a comprehensive legal framework to govern the transfer of biological materials between institutions. A Biological Material Transfer Agreement ensures that your research collaborations comply with UAE federal laws while protecting the interests of both providing and receiving parties.

When do you need this document?

You'll require this agreement whenever biological materials cross institutional boundaries for research purposes. This includes transfers between universities and pharmaceutical companies for drug development projects, sharing of cell lines between research institutions for collaborative studies, and provision of tissue samples from medical centers to biotechnology companies. The document is essential when government research centers share genetic materials with private laboratories, or when international research collaborations involve UAE-based institutions. You also need this agreement for transfers involving infectious agents, human-derived materials, or genetically modified organisms that fall under UAE regulatory oversight.

Key legal considerations

Your agreement must address several critical legal elements to ensure enforceability and compliance. Material identification clauses should precisely describe the biological substances being transferred, including their origin, characteristics, and any associated risks. Permitted use provisions must clearly define the scope of research activities, whether for commercial or non-commercial purposes, and any restrictions on redistribution to third parties. Intellectual property clauses should establish ownership rights for any discoveries, patents, or commercial developments arising from the transferred materials. Confidentiality terms protect proprietary information shared during the transfer process, while liability and indemnification clauses allocate responsibility for potential damages or regulatory violations.

Legal requirements in United Arab Emirates

Your Biological Material Transfer Agreement must comply with Federal Law No. 14 of 2014 on Communicable Diseases Control, which regulates the handling and transfer of infectious biological materials and establishes mandatory safety protocols. Under Federal Law No. 11 of 2008 on Human Medical Research, transfers involving human biological materials require specific consent procedures and ethical review compliance. You must ensure your agreement addresses biosafety framework requirements established by UAE health authorities, including proper containment levels, handling procedures, and waste disposal protocols. The agreement should incorporate provisions from Federal Law No. 28 of 2005 on Personal Status regarding consent capacity for human-derived materials, and consider intellectual property protections under Federal Law No. 7 of 2002 Concerning Copyrights and Neighboring Rights for any research outcomes or commercial applications.